Gnosis is a biotechnology company specialized in the manufacturing and sales of fermentation raw materials and natural finished products used in the pharmaceutical, nutraceutical, cosmetic, veterinary.
Gnosis is a technical term used throughout Greek philosophy describing experience-based knowledge in contrast to theoretical knowledge.
Gnosis was established in Italy in 1989, with the name Gnosis Srl. Today, the company is owned by the founder, SECI Holding and members of the company’s management team.
Successfully integrating consumer needs with R&D and GMP manufacturing enables us to constantly work to develop and introduce innovative and market leading products to our customers.
The Gnosis Group includes a European manufacturing network made up of three operating divisions and three commercial operations located in Italy, the USA and China.
Manufacturing includes two pharmaceutical cGMP approved plants, our Sant’Antonino Operations known as Gnosis Bioresearch SA (Bellinzona, Switzerland) and our Pisticci Operations known as Gnosis Bioresearch Srl (Matera, Italy). Gnosis has integrated the value chain from the development to the commercialization of its products by combining outstanding R&D with advanced manufacturing capabilities.
Via Lischedi 4
6592 S. Antonino
|T.: +41 91 851 91 91|
|F.: +41 91 851 91 92|
Main activities Drug Substance CMO ●
Therapeutic areas CNS ● Gastrointestinal ●
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● MENA ● BRICS ● ASEAN ● Australia ● Japan ●
Drug substance type APIs (>200kgs/batch) ●
Other activities (non pharma) Feed Additives ● Nutraceuticals ●